Article PDF
Avoid common mistakes on your manuscript.
References
Shenoy B, Singh S, Ahmed MZ, et al. Indian Academy of Pediatrics Position Paper on Kawasaki Disease. Indian Pediatr. 2020;57:1040–48.
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017; 135:e927–99.
Albers S, Mir TS, Haddad M, Läer S. N-terminal pro brain natriuretic peptide: Evaluation of pediatric reference values including method comparison and inter-laboratory variability. Clin Chem Lab Med. 2006;44:80–85.
Dahdah N, Fournier A. Natriuretic peptides in Kawasaki disease: The myocardial perspective. Diagnostics (Basel). 2013; 3:1–12.
Research Committee of the Japanese Society of Pediatric Cardiology; Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease. Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int. 2014;56:135–58.
Research Committee of the Japanese Society of Pediatric Cardiology; Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease. Erratum in: Pediatr Int. 2016;58:675.
Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: From the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001;90:40–4.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Prashanth, G.P., Tandon, A. & Shenoy, B. Position Paper on Kawasaki Disease in India: Pertinent Issues. Indian Pediatr 58, 190–191 (2021). https://doi.org/10.1007/s13312-021-2145-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2145-2